Bøger af Atta-ur-Rahman
-
998,95 kr. Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field. Contents of this volume include these 6 reviews: - Multicomponent synthesis of heterocycles by microwave irradiation- Stereoselective procedures for the synthesis of olefines- Advanced microwave assisted organic synthesis method in organic chemistry- Five and six-membered n-heterocycle rings from diaminomaleonitrile- Peptidomimetics: current and future perspectives on hiv protease inhibitors- A review on synthesis, chemistry, and medicinal properties of benzothiazines and their related scaffolds
- Bog
- 998,95 kr.
-
1.096,95 kr. 13C-NMR spectroscopy plays an important role in the elucidation of organic compound structures. Chemists researching new compounds will find this volume, which covers the 13C-NMR data of diterpenes, a valuable reference source.
- Bog
- 1.096,95 kr.
-
908,95 kr. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology. Volume 10 of the series continues to present novel information about new and interesting approaches to treat common neurological disorders, with a focus on neurodegeneration and pain medicine. The volume presents 7 detailed reviews in total. - Neurodegenerative disease: prevention and treatment through plant extracts therapy- Emerging novel approaches and recent advances in Parkinson's disease treatment and diagnosis- Neurotrophic factors to combat neurodegeneration- Neural bases of executive function in ADHD children as assessed using FNIRS- Modulation of mesenchymal stem cells, glial cells and the immune system by oligodeoxynucleotides as a novel multi-target therapeutic approach against chronic pain- Chronic pain: focus on anticonvulsants- A review of the impact of testosterone on brain and aging-related decline in brain behavioural function
- Bog
- 908,95 kr.
-
818,95 kr. Frontiers in Clinical Drug Research - Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology. The fifth volume of this series features 7 reviews with a focus on thalassemia treatment and preeclampsia among other topics. - Recent advances in the diagnosis and management of pulmonary embolism- An evidence-based approach to treatment with iron chelators in transfusion- dependent thalassemia patients: present trends and future scenario- Current and future treatments of iron overload in thalassemia patients- Preeclampsia: biological and clinical aspects- Haematological modulations by fixed dose combination (FDC) of tramadol hydrochloride/paracetamol (THP)- Possible use of eculizumab in critically ill patients infected with covid-19 role of complement c5, neutrophils, and nets in the induction DIC, sepsis, and MOF hematological markers- Emerging diagnostic and therapeutic targets in preeclampsia
- Bog
- 818,95 kr.
-
723,95 kr. Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field. >- Recent advances in copper-catalyzed heterocyclic syntheses- Application of modern green chemistry methods in the synthesis of quinolines, quinazolines and quinazolinones- Electroluminescence polymers-a review on synthesis by organic compounds- Multicomponent approach for the synthesis of xanthenes- From atoms to macromolecules: 100 years of polymer research- An overview of oxidizing and reducing agents in total synthesis- Amino acid-derived ionic liquids: novel biodegradable catalytic systems for green synthesis of heterocycles
- Bog
- 723,95 kr.
-
- Volume 8
998,95 kr. Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics- Prospects for therapeutic targeting of microRNAs in brain tumors- Breast cancer vaccines: current status and future approach- Desmocollin-3 and cancer- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
- Bog
- 998,95 kr.
-
993,95 - 1.198,95 kr. - Bog
- 993,95 kr.
-
- Volume 9
883,95 kr. Applications of NMR Spectroscopy is a book series devoted to publishing the latest advances in the applications of nuclear magnetic resonance (NMR) spectroscopy in various fields of organic chemistry, biochemistry, health and agriculture. >- NMR spectroscopy for the characterization of photoprotective compounds in cyanobacteria- Coffee assessment using 1H NMR spectroscopy and multivariate data analysis: a review- Evaluation of structure-property relationship of coconut shell lignins by NMR spectroscopy: from biorefinery to high-added value products- Application of NMR spectroscopy in chiral recognition of drugs- NMR-based metabolomics: general aspects and applications in cancer diagnosis
- Bog
- 883,95 kr.
-
1.121,95 kr. - Bog
- 1.121,95 kr.
-
2.171,95 kr. A step-by-step look at how simple and rapid bioassays can serve as the starting point for drug discovery, cutting development time which is both long and expensive.
- Bog
- 2.171,95 kr.